Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP911593.RABv9A8Sag3RCgXacl7HBg-LqS-E7kijinYclYFBinbo0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP911593.RABv9A8Sag3RCgXacl7HBg-LqS-E7kijinYclYFBinbo0130_assertion type Assertion NP911593.RABv9A8Sag3RCgXacl7HBg-LqS-E7kijinYclYFBinbo0130_head.
- NP911593.RABv9A8Sag3RCgXacl7HBg-LqS-E7kijinYclYFBinbo0130_assertion description "[We compare the ability of 24-hour exposure to 0.3 microg/mL (4 nM) DT388-GM-CSF to kill AML colony forming cells (CFC) and the more primitive AML progenitors detected after 6 weeks in stromal cocultures (AML LTC-initiating cells or AML LTC-IC) and after 8 weeks in NOD/SCID mice.AML samples (n = 10), expressing a mean of 35 to 1466 GM-CSF receptors/blast, showed mean (range) percent kills of AML CFC and LTC-IC of 61 (17-98) and 46 (0-94) respectively with a direct correlation (r = 0.69) between the % kills detected in the in vitro assays.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP911593.RABv9A8Sag3RCgXacl7HBg-LqS-E7kijinYclYFBinbo0130_provenance.
- NP911593.RABv9A8Sag3RCgXacl7HBg-LqS-E7kijinYclYFBinbo0130_assertion evidence source_evidence_literature NP911593.RABv9A8Sag3RCgXacl7HBg-LqS-E7kijinYclYFBinbo0130_provenance.
- NP911593.RABv9A8Sag3RCgXacl7HBg-LqS-E7kijinYclYFBinbo0130_assertion SIO_000772 11146161 NP911593.RABv9A8Sag3RCgXacl7HBg-LqS-E7kijinYclYFBinbo0130_provenance.
- NP911593.RABv9A8Sag3RCgXacl7HBg-LqS-E7kijinYclYFBinbo0130_assertion wasDerivedFrom befree-20140225 NP911593.RABv9A8Sag3RCgXacl7HBg-LqS-E7kijinYclYFBinbo0130_provenance.
- NP911593.RABv9A8Sag3RCgXacl7HBg-LqS-E7kijinYclYFBinbo0130_assertion wasGeneratedBy ECO_0000203 NP911593.RABv9A8Sag3RCgXacl7HBg-LqS-E7kijinYclYFBinbo0130_provenance.